SAS | The Power to Know
Backgrounds_84A0920
cq5dam.thumbnail.319.319
White Paper

Are You Ready for Clinical Trial Data Transparency?

What It Means for Your Business – and What’s Needed for a Successful Implementation

About this paper

Consensus is building around the idea that greater access to patient-level clinical data is a good thing – good for science, business and humanity. From a business perspective, pooling data can significantly reduce the cost of drug development while improving the efficiency of clinical trials. It can also lower clinical trial costs by reducing the number of patients needed for new studies. But data sharing and transparency raises new issues and brings a host of new questions, benefits and risks. For example, unless appro­priate safeguards are in place, open access to clinical trial data could compromise patient privacy, enable faulty science, and be a resource-intensive burden for trial sponsors and data stewards. This paper discusses different approaches to successfully implementing clinical trial data transparency while mitigating these risks.

About SAS

SAS is the leader in analytics. Through innovative software and services, SAS empowers and inspires customers around the world to transform data into intelligence. SAS gives you THE POWER TO KNOW®.

¿Tiene un Perfil SAS? Para completar este formulario automáticamente Ingreso

*
*
*
*
 
*
 
 
  Sí, deseo recibir información ocasional de SAS Institute Inc. y sus filiales y afiliados sobre los productos y servicios de SAS. En cualquier momento podré oponerme al uso de mis datos con dicha finalidad haciendo clic al enlace de opt-out existente en los correos electrónicos recibidos. Declaración de Privacidad

Toda la información personal será manejado de acuerdo al Aviso de Privacidad de SAS.

 
 

Back to Top